Search

Dr. Heng has been invited to join the roundtable panel discussion, "Driving Innovation in Precision Medicine for Broader Implementation" at the Festival of Genomics & BioData in Boston.

Dr. Heng will be an invited speaker for the "Sex and gender differences in cancer" symposium to be held at the OSSD Meeting in June 2025.

A study co-led by Dr. Heng, "Circulating Epstein-Barr virus microRNAs associated with Hodgkin lymphoma prognosis" has been selected for Poster presentation at AACR 2025.

Dr. Heng has been selected to participate in the 2025 SGM Cancer Curriculum Advances Research Excellence (CARE) Workshop in Denver, CO. She will also present relevant basic cancer research that she is leading at the workshop.

Dr. Heng will be presenting, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." at the 2025 Harvard Institute for RNA Medicine (HiRM) seminar series on Tuesday, February 18th at 3 pm.

Dr. Heng will be a keynote speaker at AI Club's annual Research Symposium. https://corp.aiclub.world/2025-student-research-symposium

Dr. Heng's abstract, "Male Immune Modulation Reduces the Efficacy of PARP Inhibition in the Treatment of Brca1 mut Breast Tumors" has been accepted for an oral presentation at the upcoming 4th Annual Reproductive Medicine Symposium. Congratulations!

Mirxes US featured two of our projects on their blog: BRCA-related breast cancer miRNA study: https://www.mirxes.us/blog/plasma-mir-362-3p-expression-linked-to-improved-cisplatin-response-in-brca-related-breast-cancer/ Hodgkin's lymphoma-related EBV miRNA study : https://www.mirxes.us/blog/mirxes...